AAAAAA

   
Results: 1-16 |
Results: 16
Molecular diversity of quinolone resistance in genetically related clinical isolates of Staphylococcus aureus and susceptibility to newer quinolones
Authors: Guiraoa, GY Toldos, MCM Peris, BM Manzanares, MAA Zufiaurre, MNG Andres, JAM Bellido, JLM Garcia-Rodriguez, JA Hernandez, MS
Citation: Gy. Guiraoa et al., Molecular diversity of quinolone resistance in genetically related clinical isolates of Staphylococcus aureus and susceptibility to newer quinolones, J ANTIMICRO, 47(2), 2001, pp. 157-161
Bacterial peritonitis due to Leclercia adecarboxylata in a patient undergoing peritoneal dialysis
Authors: Rodriguez, JA Sanchez, FJ Gutierrez, MN Garcia, JE Garcia-Rodriguez, JA
Citation: Ja. Rodriguez et al., Bacterial peritonitis due to Leclercia adecarboxylata in a patient undergoing peritoneal dialysis, ENFERM INF, 19(5), 2001, pp. 237-238
Oral cephalosporins in uncomplicated urinary tract infections
Authors: Garcia-Rodriguez, JA Bellido, JLM
Citation: Ja. Garcia-rodriguez et Jlm. Bellido, Oral cephalosporins in uncomplicated urinary tract infections, CL MICRO IN, 6, 2000, pp. 73-75
The role of fluoroquinolones in respiratory tract infections: community acquired pneumonia
Authors: Garcia-Rodriguez, JA Bellido, JLM
Citation: Ja. Garcia-rodriguez et Jlm. Bellido, The role of fluoroquinolones in respiratory tract infections: community acquired pneumonia, INT J ANT A, 16(3), 2000, pp. 281-285
Antimicrobial activity of psychotropic drugs - Selective serotonin reuptake inhibitors
Authors: Munoz-Bellido, JL Munoz-Criado, S Garcia-Rodriguez, JA
Citation: Jl. Munoz-bellido et al., Antimicrobial activity of psychotropic drugs - Selective serotonin reuptake inhibitors, INT J ANT A, 14(3), 2000, pp. 177-180
In vitro activity of newer fluoroquinolones against Stenotrophomonas maltophilia
Authors: Bellido, JLM Hernandez, FJS Zufiaurre, MNG Garcia-Rodriguez, JA
Citation: Jlm. Bellido et al., In vitro activity of newer fluoroquinolones against Stenotrophomonas maltophilia, J ANTIMICRO, 46(2), 2000, pp. 334-335
Overview of the cost-effectiveness of cefixime
Authors: Garcia-Rodriguez, JA
Citation: Ja. Garcia-rodriguez, Overview of the cost-effectiveness of cefixime, DRUGS TODAY, 36, 2000, pp. 1-5
The microbiology of moxifloxacin
Authors: Garcia-Rodriguez, JA Garcia, ACG
Citation: Ja. Garcia-rodriguez et Acg. Garcia, The microbiology of moxifloxacin, DRUGS TODAY, 36(4), 2000, pp. 215-227
In vitro activities of five new antimicrobial agents against Brucella melitensis
Authors: Trujillano-Martin, I Garcia-Sanchez, E Fresnadillo, MJ Garcia-Sanchez, JE Garcia-Rodriguez, JA Martinez, IM
Citation: I. Trujillano-martin et al., In vitro activities of five new antimicrobial agents against Brucella melitensis, INT J ANT A, 12(2), 1999, pp. 185-186
Antimicrobial susceptibility of 1,422 Haemophilus influenzae isolates fromrespiratory tract infections in Spain. Results of a 1-year (1996-97) multicenter surveillance study
Authors: Garcia-Rodriguez, JA Baquero, F de Lomas, JG Aguilar, L
Citation: Ja. Garcia-rodriguez et al., Antimicrobial susceptibility of 1,422 Haemophilus influenzae isolates fromrespiratory tract infections in Spain. Results of a 1-year (1996-97) multicenter surveillance study, INFECTION, 27(4-5), 1999, pp. 265-267
Antibiotic susceptibility among aerobic gram-negative bacilli in intensivecare units in 5 European countries
Authors: Hanberger, H Garcia-Rodriguez, JA Gobernado, M Goossens, H Nilsson, LE Struelens, MJ
Citation: H. Hanberger et al., Antibiotic susceptibility among aerobic gram-negative bacilli in intensivecare units in 5 European countries, J AM MED A, 281(1), 1999, pp. 67-71
In vitro activities of 13 fluoroquinolones against Staphylococcus aureus isolates with characterized mutations in gyrA, gyrB, grlA, and norA and against wild-type isolates
Authors: Bellido, JLM Manzanares, MAA Guirao, GY Zufiaurre, MNG Toldos, MCM Hernandez, MS Garcia-Rodriguez, JA
Citation: Jlm. Bellido et al., In vitro activities of 13 fluoroquinolones against Staphylococcus aureus isolates with characterized mutations in gyrA, gyrB, grlA, and norA and against wild-type isolates, ANTIM AG CH, 43(4), 1999, pp. 966-968
Efflux pump-mediated quinolone resistance in Staphylococcus aureus strainswild type for gyrA, gyrB, grlA, and norA
Authors: Munoz-Bellido, JL Manzanares, MAA Andres, JAM Zufiaurre, MNG Ortiz, G Hernandez, MS Garcia-Rodriguez, JA
Citation: Jl. Munoz-bellido et al., Efflux pump-mediated quinolone resistance in Staphylococcus aureus strainswild type for gyrA, gyrB, grlA, and norA, ANTIM AG CH, 43(2), 1999, pp. 354-356
Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: Results of a 1-year (1996-1997) multicenter surveillance study
Authors: Baquero, F Garcia-Rodriguez, JA de Lomas, JG Aguilar, L
Citation: F. Baquero et al., Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: Results of a 1-year (1996-1997) multicenter surveillance study, ANTIM AG CH, 43(2), 1999, pp. 357-359
Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: Results of a 1-year (1996-1997) multicenter surveillance study
Authors: Baquero, F Garcia-Rodriguez, JA de Lomas, JG Aguilar, L
Citation: F. Baquero et al., Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: Results of a 1-year (1996-1997) multicenter surveillance study, ANTIM AG CH, 43(1), 1999, pp. 178-180
In vitro activities of six new fluoroquinolones against Brucella melitensis
Authors: Trujillano-Martin, I Garcia-Sanchez, E Martinez, IM Fresnadillo, MJ Garcia-Sanchez, JE Garcia-Rodriguez, JA
Citation: I. Trujillano-martin et al., In vitro activities of six new fluoroquinolones against Brucella melitensis, ANTIM AG CH, 43(1), 1999, pp. 194-195
Risultati: 1-16 |